Insights from 2023 SABCS


 

SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib + Fulvestrant +/- Palbociclib in Patients With HR+/ HER2- aBC Previously Treated With CDK4/6i + Non-Steroidal Aromatase Inhibitor"

298 views
December 12, 2023
Comments 0
Login to view comments. Click here to Login